Advertisement

Identity of Somatoform Disorders: Comparison with Depressive Disorders and Anxiety Disorders

Chapter

Abstract

Somatoform disorders are among the most prevalent psychiatric disorders in general practice. A somatoform disorder was diagnosed in 16.1 % of consecutive consulting patients [1]. Patients with somatoform disorders are often referred to as “medical orphans” [2], because correct diagnosis is not made by physicians and the patients end up “shopping” for diagnoses by visiting many physicians.

Keywords

Anxiety Disorder Somatic Symptom Panic Disorder Health Anxiety Major Depressive Disorder Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    De Waal, M. W., Arnold, I. A., Eekhof, J. A., et al. (2004). Somatoform disorders in general practice: Prevalence, functional impairment and comorbidity with anxiety and depressive disorders. The British Journal of Psychiatry, 184, 470–476.PubMedCrossRefGoogle Scholar
  2. 2.
    Aronowitz, R. A. (2001). When do symptoms become a disease? Annals of Internal Medicine, 134, 803–808.PubMedCrossRefGoogle Scholar
  3. 3.
    Dimsdale, J. E., & Dantzer, R. (2007). A biological substrate for somatoform disorders: Importance of pathophysiology. Psychosomatic Medicine, 69, 850–854.PubMedCrossRefGoogle Scholar
  4. 4.
    Rief, W., & Rojas, G. (2007). Stability of somatoform symptoms – implications for classification. Psychosomatic Medicine, 69, 864–869.PubMedCrossRefGoogle Scholar
  5. 5.
    Mayou, R., Kirmayer, L. J., Simon, G., et al. (2005). Somatoform disorders: Time for a new approach in DSM-V. The American Journal of Psychiatry, 162, 847–855.PubMedCrossRefGoogle Scholar
  6. 6.
    Bass, C. M., & Murphy, M. R. (1990). Somatization disorder: Critique of the concept and suggestions for further research. In C. M. Bass & R. H. Cawley (Eds.), Somatization: Physical symptoms and psychological illness. Oxford, UK: Blackwell Scientific.Google Scholar
  7. 7.
    Rost, K. M., Atkins, R. M., Brown, F. W., et al. (2003). The comorbidity of DSM-III-R personality disorders in somatization disorder. General Hospital Psychiatry, 14, 322–326.CrossRefGoogle Scholar
  8. 8.
    Simon, G. E., & Gureje, O. (1999). Stability of somatization disorder and somatization symptoms among primary care patients. Archives of General Psychiatry, 56, 90–95.PubMedCrossRefGoogle Scholar
  9. 9.
    Katon, W., Lin, E., Von Korff, M., et al. (1991). Somatization: A spectrum of severity. The American Journal of Psychiatry, 148, 34–40.PubMedGoogle Scholar
  10. 10.
    Barsky, A. J., Wyshak, G., & Klerman, G. L. (2003). Hypochondriasis: An evaluation of the DSM-III criteria in medical outpatients. Archives of General Psychiatry, 43, 493–500.CrossRefGoogle Scholar
  11. 11.
    Salkovskis, P. M., & Warwick, H. M. (1986). Morbid preoccupation, health anxiety and reassurance: A cognitive-behavioral approach to hypochondriasis. Behaviour Research and Therapy, 24, 597–602.PubMedCrossRefGoogle Scholar
  12. 12.
    Hyler, S. E., & Spitzer, R. L. (1978). Hysteria split asunder. The American Journal of Psychiatry, 135, 1500–1504.PubMedGoogle Scholar
  13. 13.
    Martin, R. L. (1992). Diagnostic issues for conversion disorder. Hospital & Community Psychiatry, 43, 771–773.Google Scholar
  14. 14.
    Chang, D. F., Myers, H. F., Yeung, A., et al. (2005). Shenjing shuairuo and the DSM-IV: Diagnosis, distress, and disability in a Chinese primary care setting. Transcultural Psychiatry, 42, 204–218.PubMedCrossRefGoogle Scholar
  15. 15.
    LeiKeiknes, K. A., Finset, A., Mount, T., et al. (2007). Current somatoform disorders in Norway: Prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders. Social Psychiatry and Psychiatric Epidemiology, 42, 698–710.CrossRefGoogle Scholar
  16. 16.
    Sullivan, M. D. (2000). DSM-IV pain disorder: A case against the diagnosis. International Review of Psychiatry, 12, 91–98.CrossRefGoogle Scholar
  17. 17.
    Phillips, K. A., McElroy, S. L., Hudson, J. I., et al. (1995). Body dysmorphic disorder: An obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? The Journal of Clinical Psychiatry, 56(suppl. 4), 41–51.PubMedGoogle Scholar
  18. 18.
    Lowe, B., Mundt, M., Herzog, W., et al. (2008). Validity of current somatoform disorder diagnoses: Perspectives for classification in DSM-V and ICD-11. Psychopathology, 41, 4–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Kroenke, K., Sharpe, M., Sykes, R., et al. (2007). Revising the classification of somatoform disorders: Key questions and preliminary recommendations. Psychosomatics, 48, 277–285.PubMedCrossRefGoogle Scholar
  20. 20.
    Janka, A. (2005). Rethinking somatoform disorders. Current Opinion in Psychiatry, 18, 65–71.Google Scholar
  21. 21.
    Creed, F. (2006). Can DSM-V facilitate productive research into the somatoform disorders? Journal of Psychosomatic Research, 60, 331–334.PubMedCrossRefGoogle Scholar
  22. 22.
    Smith, R., Gardiner, J., Lyles, J., et al. (2005). Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosomatic Medicine, 67, 123–129.PubMedCrossRefGoogle Scholar
  23. 23.
    Hanel, G., Henningsen, P., Herzog, W., et al. (2009). Depression, anxiety, and somatoform disorders: Vague or distinct categories in primary care? Results from a large cross-sectional study. Journal of Psychosomatic Research, 67, 189–197.PubMedCrossRefGoogle Scholar
  24. 24.
    Duddu, V., Isaac, M. K., Chaturvedi, S. K., et al. (2006). Somatization, somatosensory amplification, attribution styles and illness behavior: A review. International Review of Psychiatry, 18, 25–33.PubMedCrossRefGoogle Scholar
  25. 25.
    Koh, K. B., & Ki, S. W. (1997). A comparison of illness behavior among patients with somatoform disorders, depressive disorders and psychosomatic disorders. Korean Journal of Psychosomatic Medicine, 5, 185–194.Google Scholar
  26. 26.
    Rief, W., Hiller, W., & Margraf, J. (1998). Cognitive aspects of hypochondriasis and the somatization syndrome. Journal of Abnormal Psychology, 107, 587–595.PubMedCrossRefGoogle Scholar
  27. 27.
    Aggarwal, V. R., McBeth, J., Zakrzewska, J. M., et al. (2006). The epidemiology of chronic syndromes that are frequently unexplained: Do they have common associated factors? [see comment]. International Journal of Epidemiology, 35, 468–476.PubMedCrossRefGoogle Scholar
  28. 28.
    Noyes, R., Stuart, S., Watson, D. B., et al. (2006). Distinguishing between hypochondriasis and somatization disorder: A review of the existing literature. Psychotherapy and Psychosomatics, 75, 270–281.PubMedCrossRefGoogle Scholar
  29. 29.
    Koh, K. B., Kim, C. H., & Park, J. K. (2002). Predominance of anger in depressive disorder compared to anxiety disorder and somatoform disorder. The Journal of Clinical Psychiatry, 63, 486–492.PubMedCrossRefGoogle Scholar
  30. 30.
    Koh, K. B., Kim, D. K., Kim, S. Y., et al. (2008). The relation between anger management style, mood, and somatic symptoms in anxiety disorders and somatoform disorders. Psychiatry Research, 160, 372–379.PubMedCrossRefGoogle Scholar
  31. 31.
    Koh, K. B., Kim, D. K., Kim, S. Y., et al. (2005). The relation between anger expression, depression, and somatic symptoms in depressive disorders and somatoform disorders. The Journal of Clinical Psychiatry, 66, 485–491.PubMedCrossRefGoogle Scholar
  32. 32.
    Shipko, S. (1982). Alexithymia and somatization. Psychotherapy and Psychosomatics, 37, 193–201.PubMedCrossRefGoogle Scholar
  33. 33.
    Burba, B., Oswald, R., Grigaliunien, V., et al. (2006). A controlled study of alexithymia in adolescent patients with persistent somatoform pain disorder. Canadian Journal of Psychiatry, 51, 468–471.Google Scholar
  34. 34.
    Nunez, G., Rufer, M., Leenen, K., et al. (2010). Quality of life and alexithymia in somatoform pain disorder. Schmerz, 24, 62–68.CrossRefGoogle Scholar
  35. 35.
    Koh, K. B. (1994). Comparison of alexithymia among patients with psychosomatic disorders, anxiety disorders and depressive disorders. Korean Journal of Psychosomatic Medicine, 2, 59–68.Google Scholar
  36. 36.
    Rief, W., & Broadbent, E. (2007). Explaining medically unexplained symptoms-models and mechanisms. Clinical Psychology Review, 27, 821–841.PubMedCrossRefGoogle Scholar
  37. 37.
    Kolk, A. M., Schagen, S., & Hanewald, G. J. (2004). Multiple medically unexplained physical symptoms and health care utilization: Outcome of psychological intervention and patient-related predictors of change. Journal of Psychosomatic Research, 57, 379–389.PubMedGoogle Scholar
  38. 38.
    Rief, W., Martin, A., Klaiberg, A., et al. (2005). Specific effects of depression, panic, and somatic symptoms on illness behavior. Psychosomatic Medicine, 67, 596–601.PubMedCrossRefGoogle Scholar
  39. 39.
    Guggenheim, F. G. (2000). Somatoform disorder. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed.). Baltimore, MD: Lippincott Williams & Wilkins.Google Scholar
  40. 40.
    Koh, K. B. (2002). Stress and psychosomatic medicine (pp. 231–249). Seoul, Korea: Ilchokak.Google Scholar
  41. 41.
    Mezzich, J. E., Lin, K., & Hughes, C. C. (2000). Acute and transient psychotic disorders and culture bound syndromes. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed., pp. 1264–1276). Baltimore, MD: Lippincott Williams & Wilkins.Google Scholar
  42. 42.
    Lin, K. M. (1983). Hwa-byung: A Korean culture-bound syndrome? The American Journal of Psychiatry, 140, 105–107.PubMedGoogle Scholar
  43. 43.
    Min, S. K. (1989). A study of the concept of hwabyung. Journal of Korean Neuropsychiatric Association, 28, 604–616.Google Scholar
  44. 44.
    Lee, S., & Kleinman, A. (2007). Are somatoform disorders changing with time? The case of neurasthenia in China. Psychosomatic Medicine, 69, 846–849.PubMedCrossRefGoogle Scholar
  45. 45.
    Leiknes, K. A., Finset, A., & Moum, T. (2010). Commonalities and differences between the diagnostic groups: Current somatoform disorders, anxiety and/or depression, and musculoskeletal disorders. Journal of Psychosomatic Research, 68, 439–446.PubMedCrossRefGoogle Scholar
  46. 46.
    Nutt, D. J., & Stein, D. J. (2006). Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectrums, 11, 13–20.PubMedGoogle Scholar
  47. 47.
    Koh, K. B., Kang, J. I., Lee, J. D., et al. (2010). Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls. The Journal of Clinical Psychiatry, 71, 1576–1581.PubMedCrossRefGoogle Scholar
  48. 48.
    Valet, M., Gundel, H., Sprenger, T., et al. (2009). Patients with pain disorder show gray-matter loss in pain-processing structures: A voxel-based morphometric study. Psychosomatic Medicine, 71, 49–56.PubMedCrossRefGoogle Scholar
  49. 49.
    Uchida, R. R., Del-Ben, C. M., Busatto, G. F., et al. (2008). Regional gray matter abnormalities in panic disorder: A voxel-based morphometry study. Psychiatry Research, 163, 21–29.PubMedCrossRefGoogle Scholar
  50. 50.
    van Tol, M.-J., van der Wee, N. J. A., van den Heuvel, O. A., et al. (2010). Regional brain volume in depression and anxiety disorders. Archives of General Psychiatry, 67, 1002–1011.PubMedCrossRefGoogle Scholar
  51. 51.
    Drevets, W. C. (2001). Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology, 11, 240–249.PubMedCrossRefGoogle Scholar
  52. 52.
    Koh, K. B., Choi, E. H., Lee, Y., et al. (2011). Serotonin-related gene pathways associated with undifferentiated somatoform disorder. Psychiatry Research, 189, 246–250.PubMedCrossRefGoogle Scholar
  53. 53.
    Koh, K. B., Kim, C. H., Choi, E. H., et al. (2012). Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. The Journal of Clinical Psychiatry, 73, e574–e579.PubMedCrossRefGoogle Scholar
  54. 54.
    Zill, P., Baghai, T. C., Zwanzger, P., et al. (2004). SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Molecular Psychiatry, 9, 1030–1036.PubMedCrossRefGoogle Scholar
  55. 55.
    Oquendo, M. A., & Mann, J. J. (2001). Neuroimaging findings in major depression, suicidal behavior and aggression. Clinical Neuroscience Research, 1, 377–380.CrossRefGoogle Scholar
  56. 56.
    Rosenthal, N. E., Mazzanti, C. M., Barnett, R. L., et al. (1998). Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder. Molecular Psychiatry, 3, 175–177.PubMedCrossRefGoogle Scholar
  57. 57.
    Maron, E., Hettema, J. M., & Shlik, J. (2010). Advances in molecular genetics of panic disorder. Molecular Psychiatry, 15, 681–701.PubMedCrossRefGoogle Scholar
  58. 58.
    Koh, K. B., Sohn, S.-H., Kang, J. I., et al. (2012). Relationship between neural activity and immunity in patients with undifferentiated somatoform disorder. Psychiatry Research: Neuroimaging, 202, 252–256.PubMedCrossRefGoogle Scholar
  59. 59.
    Schleifer, S. J., Keller, S. E., Scotte, B. J., et al. (1990). Lymphocyte function in panic disorder. Biological Psychiatry, 27(suppl. 9A), 66A.Google Scholar
  60. 60.
    Surman, O. S., Williams, J., Sheehan, D. V., et al. (1986). Immunological response to stress in agoraphobia and panic attacks. Biological Psychiatry, 21, 768–774.PubMedCrossRefGoogle Scholar
  61. 61.
    Brambilla, F., Bellodi, L., Perna, G., et al. (1992). Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology, 26, 12–22.PubMedCrossRefGoogle Scholar
  62. 62.
    Andreoil, A., Keller, S. E., Taban, C., et al. (1990). Immune function in major depressive disorder: Relation to panic disorder comorbidity. Biological Psychiatry, 27(suppl. 9A), 95A.Google Scholar
  63. 63.
    Koh, K. B., & Lee, B. K. (1998). Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosomatic Medicine, 60, 479–483.PubMedGoogle Scholar
  64. 64.
    Koh, K. B., & Lee, Y. (2004). Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychotherapy and Psychosomatics, 73, 286–292.PubMedCrossRefGoogle Scholar
  65. 65.
    Marazziti, D., Ambrogi, F., Vanacore, R., et al. (1992). Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology, 26, 23–26.PubMedCrossRefGoogle Scholar
  66. 66.
    Irwin, M. R., & Miller, A. H. (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity, 21, 374–383.PubMedCrossRefGoogle Scholar
  67. 67.
    Zorrilla, E. P., Luborsky, L., McKay, J. R., et al. (2001). The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain, Behavior, and Immunity, 15, 199–226.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of PsychiatryYonsei University College of MedicineSeodaemun-gu, SeoulKorea

Personalised recommendations